http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010045529-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d80dc4f170dc3425d56f51dd16c0403e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cea17343c7ce54b4990b457f9a35dbef
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
filingDate 2009-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4bddbe76418957c896058b6a6de4578
publicationDate 2010-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010045529-A3
titleOfInvention Combination therapies for the treatment of obesity
abstract Described are pharmaceutical compositions comprising diethylpropion, metformin, orlistat, and at least one pharmaceutically acceptable carrier or excipient. Another aspect of the present invention relates to a method of treating a patient suffering from obesity or needing to lose weight, comprising the step of co-administering to said patient a therapeutically effective amount of diethylpropion, metformin, and orlistat. In certain embodiments, an aforementioned method is practiced in conjunction or tandem with a medical procedure or the use of a medical device or both.
priorityDate 2008-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007244130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004204472-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6686337-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7115640-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007060532-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497074

Total number of triples: 31.